Immix Biopharma, Inc.
IMMX
$1.99
-$0.128-6.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.64M | 15.92M | 17.68M | 19.69M | 23.98M |
| Total Receivables | -- | -- | 1.97M | 1.98M | 1.98M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 549.80K | 689.70K | 509.20K | 1.05M | 1.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 137.70K | 168.40K | 32.30K | 36.50K | 105.80K |
| Total Current Assets | 12.33M | 16.78M | 20.20M | 22.76M | 27.33M |
|
|
|||||
| Total Current Assets | 12.33M | 16.78M | 20.20M | 22.76M | 27.33M |
| Net Property, Plant & Equipment | 3.18M | 3.09M | 2.73M | 2.37M | 1.48M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 131.00K | 20.40K | 20.40K | 20.40K | 20.40K |
| Total Assets | 15.64M | 19.89M | 22.95M | 25.14M | 28.84M |
|
|
|||||
| Total Accounts Payable | 6.61M | 5.74M | 5.39M | 3.29M | 2.35M |
| Total Accrued Expenses | 3.32M | 3.50M | 3.23M | 3.21M | 1.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 70.50K | 67.80K | 65.20K | 62.70K | 48.40K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.01M | 9.31M | 8.69M | 6.56M | 3.90M |
|
|
|||||
| Total Current Liabilities | 10.01M | 9.31M | 8.69M | 6.56M | 3.90M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 972.30K | 991.10K | 1.01M | 1.03M | 1.04M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.98M | 10.30M | 9.70M | 7.59M | 4.94M |
|
|
|||||
| Common Stock & APIC | 90.88M | 89.25M | 88.38M | 87.67M | 86.94M |
| Retained Earnings | -86.19M | -79.57M | -75.02M | -70.21M | -63.06M |
| Treasury Stock & Other | -34.90K | -84.50K | -101.00K | 92.10K | 17.00K |
| Total Common Equity | 4.65M | 9.59M | 13.25M | 17.55M | 23.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.65M | 9.59M | 13.25M | 17.55M | 23.89M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.65M | 9.59M | 13.25M | 17.55M | 23.89M |
|
|
|||||